Showing results (61-70 of 858) with videos related to
Sort By:
Pageof 86
Tropical Medicine & International Health : TM & IH|July 2, 2004
Time course of coagulation parameters, cytokines and adhesion molecules in Plasmodium falciparum malariaAlexander Vogetseder, Caroline Ospelt, Markus Reindl, et al.Neurology(R) Neuroimmunology & Neuroinflammation|November 22, 2022
More Efficient Complement Activation by Anti-Aquaporin-4 Compared With Anti-Myelin Oligodendrocyte Glycoprotein AntibodiesMagdalena Lerch, Kathrin Schanda, Eliott Lafon, et al.Cell and Tissue Research|April 25, 2003
GDNF and TGF-beta1 promote cell survival in serum-free cultures of primary rat microgliaKayvon Salimi, Karma V Moser, Josef Marksteiner, et al.Trends in Neurosciences|July 27, 2005
Animal models of multiple system atrophyNadia Stefanova, François Tison, Markus Reindl, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 18, 2019
Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseasesLivia S Hofer, Sara Mariotto, Sebastian Wurth, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 7, 2006
Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophyMartin Köllensperger, Nadia Stefanova, Markus Reindl, et al.Brain : a Journal of Neurology|May 24, 2003
A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesionsHans Lassmann, Markus Reindl, Helmut Rauschka, et al.Journal of the Neurological Sciences|January 29, 2010
Current therapeutic recommendations in multiple sclerosisThomas BergerSystems & Control Letters|January 3, 2022
Feedback control of the COVID-19 pandemic with guaranteed non-exceeding ICU capacityThomas BergerExpert Review of Neurotherapeutics|February 2, 2013
Multiple sclerosis spasticity daily management: retrospective data from EuropeThomas BergerPageof 86